Viewing Study NCT01603212

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:11 PM
Ignite Modification Date: 2026-02-24 @ 11:46 PM
Study NCT ID: NCT01603212
Status: COMPLETED
Last Update Posted: 2019-05-21
First Post: 2012-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Melanoma View
None Metastatic melanoma View
None Advanced melanoma View
None Vemurafenib View
None PLX4032 View
None RO5185426 View
None IL-2 View
None Interleukin-2 View
None Aldesleukin View
None Proleukin View
None Interferon Alfa-2b View
None Intron A View